drugset / Trial / NCT01373398
Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)
NaSingle-groupOpen-label
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of intravesical instillation of EO9 in patients with non-muscle invasive bladder cancer (NMIBC).
Timeline
- Start
- 2011-05
- Primary completion
- 2012-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apaziquone | Unknown | 4 mg/ml | Other |